The story appears on

Page A4

July 18, 2018

GET this page in PDF

Free for subscribers

View shopping cart

Related News

Home » Metro » Society

Progress for Alzheimer’s researchers

A Shanghai-based research group yesterday announced progress in developing a drug to treat Alzheimer’s disease.

GV-971 was developed by Ocean University of China, Shanghai Institute of Materia Medica under the Chinese Academy of Sciences and Green Valley Pharmaceutical Co, after a 21-year study.

A phase three clinical trial is the last test before reaching the market.

Extracted from brown algae, the drug is targeted at patients with mild-to-moderate Alzheimer’s. Independent animal experiments also showed it can regulate the immune system, reduce neuro-inflammation and improve cognition.

Alzheimer’s disease is an irreversible, progressive brain disorder that slowly destroys memory, thinking skills, and the ability to carry out simple tasks. The disease affects about 48 million people worldwide, and the number is expected to increase with the aging population.




 

Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.

沪公网安备 31010602000204号

Email this to your friend